Loading...

Farnaz Hasteh

TitleClinical Professor
InstitutionUniversity of California San Diego
DepartmentPathology
Address9300 Campus Point Drive #7723
La Jolla CA 92037
Phone858-657-5174
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zare S, Mirsadraei L, Reisian N, Liao X, Roma A, Shabaik A, Hasteh F. A Single Institutional Experience With the Paris System for Reporting Urinary Cytology: Correlation of Cytology and Histology in 194 Cases. Am J Clin Pathol. 2018 Jun 06. PMID: 29878037.
      View in: PubMed
    2. Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst. 2018 Jan 19. PMID: 29361175.
      View in: PubMed
    3. Hariri N, Roma AA, Hasteh F, Walavalkar V, Fadare O. Phenotypic alterations in breast cancer associated with neoadjuvant chemotherapy: A comparison with baseline rates of change. Ann Diagn Pathol. 2017 Dec; 31:14-19. PMID: 29146052.
      View in: PubMed
    4. Hariri N, Hasteh F, Walavalkar V, Roma AA, Fadare O. Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer: Assessing the Value of Repeated Centralized Testing in Excision Specimens. Appl Immunohistochem Mol Morphol. 2017 May 25. PMID: 28549033.
      View in: PubMed
    5. Solomon JP, Dell'Aquila M, Fadare O, Hasteh F. Her2/neu Status Determination in Breast Cancer: A Single Institutional Experience Using a Dual-Testing Approach With Immunohistochemistry and Fluorescence In Situ Hybridization. Am J Clin Pathol. 2017 Apr 01; 147(4):432-437. PMID: 28340220.
      View in: PubMed
    6. Bao L, Messer K, Schwab R, Harismendy O, Pu M, Crain B, Yost S, Frazer KA, Rana B, Hasteh F, Wallace A, Parker BA. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors. PLoS One. 2015; 10(11):e0142487. PMID: 26554380; PMCID: PMC4640562.
    7. Engelberg JA, Retallack H, Balassanian R, Dowsett M, Zabaglo L, Ram AA, Apple SK, Bishop JW, Borowsky AD, Carpenter PM, Chen YY, Datnow B, Elson S, Hasteh F, Lin F, Moatamed NA, Zhang Y, Cardiff RD. "Score the Core" Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Hum Pathol. 2015 Nov; 46(11):1694-704. PMID: 26410019.
      View in: PubMed
    8. Kavusi S, Paravar T, Hasteh F, Lee R. Atypical eruption but still Still's: case report and review of the literature. Int J Dermatol. 2015; 54(5):e154-9. PMID: 24898779.
      View in: PubMed
    9. McElroy MK, Mahooti S, Hasteh F. A single institution experience with the new bethesda system for reporting thyroid cytopathology: correlation with existing cytologic, clinical, and histological data. Diagn Cytopathol. 2014 Jul; 42(7):564-9. PMID: 24431292.
      View in: PubMed
    10. Kwong WT, Coyle WJ, Hasteh F, Peterson MR, Savides TJ, Krinsky ML. Malignant cell contamination may lead to false-positive findings at endosonographic fine needle aspiration for tumor staging. Endoscopy. 2014 Feb; 46(2):149-52. PMID: 24415526.
      View in: PubMed
    11. Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res. 2013 Dec 10; 15(6):R115. PMID: 24326041; PMCID: PMC3978701.
    12. Carrigg A, Teschendorf C, Amaro D, Weidner N, Tipps A, Shabaik A, Peterson MR, Lin GY, Hasteh F. Examination of sources of diagnostic error leading to cervical cone biopsies with no evidence of dysplasia. Am J Clin Pathol. 2013 Apr; 139(4):422-7. PMID: 23525611.
      View in: PubMed
    13. Baker JL, Hasteh F, Blair SL. Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines? Int J Surg Oncol. 2012; 2012:297832. PMID: 23304477; PMCID: PMC3529487.
    14. Wong D, Teschendorf C, Lin GY, Hasteh F. The clinical significance of "squamous intraepithelial lesion of indeterminate grade" as a distinct cytologic category. Am J Clin Pathol. 2012 May; 137(5):753-60. PMID: 22523214.
      View in: PubMed
    15. Johnson RL, Hasteh F. Thyroid cyst wall atypia in a patient with a history of malignant melanoma: a pitfall in fine-needle aspiration cytology. Diagn Cytopathol. 2013 Aug; 41(8):716-9. PMID: 22351646.
      View in: PubMed
    16. Papanicolau-Sengos A, Brumund K, Lin G, Hasteh F. Cytologic findings of a clear cell parathyroid lesion. Diagn Cytopathol. 2013 Aug; 41(8):725-8. PMID: 22144114.
      View in: PubMed
    17. Ruidiaz ME, Cortes-Mateos MJ, Sandoval S, Martin DT, Wang-Rodriguez J, Hasteh F, Wallace A, Vose JG, Kummel AC, Blair SL. Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device. J Surg Oncol. 2011 Dec; 104(7):746-54. PMID: 21744349.
      View in: PubMed
    18. Kerber CW, Pakbaz RS, Hasteh F, Miskolczi L, Lieber BB. 1-hexyl n-cyanoacrylate compound (Neucrylate™ AN), a new berry aneurysm treatment. II. Rabbit implant studies: technique and histology. J Neurointerv Surg. 2012 Jan 01; 4(1):50-7. PMID: 21990450.
      View in: PubMed
    19. Shabaik A, Lin G, Peterson M, Hasteh F, Tipps A, Datnow B, Weidner N. Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma. Diagn Cytopathol. 2011 May; 39(5):328-32. PMID: 21488175.
      View in: PubMed
    20. Hasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010 Apr 25; 118(2):90-6. PMID: 20209622.
      View in: PubMed
    21. Lee J, Hasteh F. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature. Diagn Cytopathol. 2009 Aug; 37(8):600-6. PMID: 19526577.
      View in: PubMed
    22. Michael CW, Pang Y, Pu RT, Hasteh F, Griffith KA. Cellular adequacy for thyroid aspirates prepared by ThinPrep: how many cells are needed? Diagn Cytopathol. 2007 Dec; 35(12):792-7. PMID: 18008342.
      View in: PubMed
    23. Hasteh F, Pang Y, Pu R, Michael CW. Do we need more than one ThinPrep to obtain adequate cellularity in fine needle aspiration? Diagn Cytopathol. 2007 Nov; 35(11):740-3. PMID: 17924406.
      View in: PubMed
    24. Steinmetz C, Shabaik A, Hasteh F. Systemic mastocytosis associated with small lymphocytic lymphoma: an incidental finding in a patient with invasive gastric adenocarcinoma. Diagn Cytopathol. 2007 Nov; 35(11):728-33. PMID: 17924405.
      View in: PubMed
    25. Hasteh F, Pu R, Michael CW. A metastatic renal carcinoid tumor presenting as breast mass: a diagnostic dilemma. Diagn Cytopathol. 2007 May; 35(5):306-10. PMID: 17427210.
      View in: PubMed
    26. Akbar SA, Sayyed TA, Jafri SZ, Hasteh F, Neill JS. Multimodality imaging of paratesticular neoplasms and their rare mimics. Radiographics. 2003 Nov-Dec; 23(6):1461-76. PMID: 14615558.
      View in: PubMed
    27. Adsay NV, Hasteh F, Cheng JD, Bejarano PA, Lauwers GY, Batts KP, Klöppel G, Klimstra DS. Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol. 2002 May; 15(5):492-501. PMID: 12011254.
      View in: PubMed